Get started
Author

Silverio Tomao

Albumin-bound formulation of paclitaxel (Abraxane® ABI-007) in the treatment of breast cancer
2009 · Silverio Tomao · International Journal of Nanomedicine · 737
PDF
Immunotherapy in HER2-positive breast cancer: state of the art and future perspectives
2019 · E. Krasniqi, G. Barchiesi, et al. · Journal of Hematology & Oncology · 132
PDF
Emerging role of cancer stem cells in the biology and treatment of ovarian cancer: basic knowledge and therapeutic possibilities for an innovative approach
2013 · Federica Tomao, Anselmo Papa, et al. · Journal of Experimental & Clinical Cancer Research · 94
PDF
Prexasertib, a checkpoint kinase inhibitor: from preclinical data to clinical development
2019 · Gesuino Angius, Silverio Tomao, et al. · Cancer Chemotherapy and Pharmacology · 72
A retrospective multicentric observational study of trastuzumab emtansine in HER2 positive metastatic breast cancer: a real-world experience
2017 · Patrizia Vici, Laura Pizzuti, et al. · Oncotarget · 69
PDF
Emerging Biological Treatments for Uterine Cervical Carcinoma
2014 · Patrizia Vici, Luciano Mariani, et al. · Journal of Cancer · 56
Immunologic treatments for precancerous lesions and uterine cervical cancer
2014 · Patrizia Vici, Luciano Mariani, et al. · Journal of Experimental & Clinical Cancer Research · 48
PDF
Niraparib in ovarian cancer: results to date and clinical potential
2017 · Davide Caruso, Anselmo Papa, et al. · Therapeutic Advances in Medical Oncology · 40
PDF
A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study
2018 · Teresa Gamucci, Laura Pizzuti, et al. · Cancer Biology & Therapy · 39
PDF
Letrozole combined with gonadotropin-releasing hormone analog for metastatic male breast cancer
2013 · Luigi Di Lauro, Patrizia Vici, et al. · Breast Cancer Research and Treatment · 35
Current role and safety profile of aromatase inhibitors in early breast cancer
2011 · Federica Tomao, GianPaolo Spinelli, et al. · Expert Review of Anticancer Therapy · 35
Fertility drugs, reproductive strategies and ovarian cancer risk
2014 · Federica Tomao, Giuseppe Lo Russo, et al. · Journal of Ovarian Research · 33
PDF
Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real‐world evidence
2020 · Eriseld Krasniqi, Laura Pizzuti, et al. · Journal of Cellular Physiology · 31
Observational study of coagulation activation in early breast cancer: development of a prognostic model based on data from the real world setting
2018 · Chiara Mandoj, Laura Pizzuti, et al. · Journal of Translational Medicine · 25
PDF
Docetaxel, oxaliplatin, and capecitabine combination chemotherapy for metastatic gastric cancer
2013 · Luigi Di Lauro, Patrizia Vici, et al. · Gastric Cancer · 25
Ovarian function, reproduction and strategies for fertility preservation after breast cancer
2010 · Federica Tomao, Gian Paolo Spinelli, et al. · Critical Reviews in Oncology/Hematology · 25
Eribulin in Triple Negative Metastatic Breast Cancer: Critic Interpretation of Current Evidence and Projection for Future Scenarios
2019 · Laura Pizzuti, Eriseld Krasniqi, et al. · Journal of Cancer · 24
PDF
Fasting glucose and body mass index as predictors of activity in breast cancer patients treated with everolimus-exemestane: The EverExt study
2017 · Laura Pizzuti, Paolo Marchetti, et al. · Scientific Reports · 20
PDF
Gemcitabine-oxaliplatin (GEMOX) as salvage treatment in pretreated epithelial ovarian cancer patients
2013 · Patrizia Vici, Domenico Sergi, et al. · Journal of Experimental & Clinical Cancer Research · 19
PDF
Vaginal atrophy in breast cancer survivors: role of vaginal estrogen therapy
2012 · Luciano Mariani, Angiolo Gadducci, et al. · Gynecological Endocrinology · 18
Breast cancer risk after exposure to fertility drugs
2013 · Giuseppe Lo Russo, Gian Paolo Spinelli, et al. · Expert Review of Anticancer Therapy · 16
Correlation between fertility drugs use and malignant melanoma incidence: the state of the art
2014 · Federica Tomao, Anselmo Papa, et al. · Tumor Biology · 14
The Potential Role of Genomic Signature in Stage II Relapsed Colorectal Cancer (CRC) Patients: A Mono-Institutional Study
2022 · Michela Roberto, Giulia Arrivi, et al. · Cancer Management and Research · 10
PDF
Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti‐HER2 agents in the real world setting
2019 · Laura Pizzuti, Eriseld Krasniqi, et al. · International Journal of Cancer · 10
PDF
Critical appraisal of bevacizumab in the treatment of metastatic colorectal cancer
2012 · Luigi Rossi, Federica Zoratto, et al. · OncoTargets and Therapy · 9
PDF
Works count: 109
Citation count: 1,691
H-index: 19
I10-index: 24
Year
Topic
Type